Human LZTR1/BTBD29/LZTR-1 ORF/cDNA clone-Lentivirus particle (NM_006767.4)

Cat. No.: vGMLV001650

Pre-made Human LZTR1/BTBD29/LZTR-1 Lentiviral expression plasmid for LZTR1 lentivirus packaging, LZTR1 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.

The GM Vector Core (GMVC) specializes in custom lentivirus development and offers a range of lentivirus manufacturing solutions, leveraging state-of-the-art processes. Learn more about our services.

pdf MSDS
pdf Datasheet

Product information

Catalog No. Product Name lentivirus Grade lentivirus quantity
vGMLV001650 Human LZTR1 Lentivirus particle Pilot Grade 1.0E+8TU
5.0E+8TU
1.0E+9TU
Research Grade 1.0E+8TU
5.0E+8TU
1.0E+9TU
GMP-like Grade inquiry
GMP Grade inquiry


Product Description

Catalog ID vGMLV001650
Gene Name LZTR1
Accession Number NM_006767.4
Gene ID 8216
Species Human
Product Type Lentivirus particle (overexpression)
Insert Length 2523 bp
Gene Alias BTBD29,LZTR-1,NS10,NS2,SWNTS2
Fluorescent Reporter Null
Mammalian Cell Selection Puromyocin
Fusion Tag 3xflag (C-Terminal)
Promoter CMV
Resistance Amplicin
ORF Nucleotide Sequence ATGGCTGGACCGGGCAGCACGGGGGGGCAGATCGGGGCTGCGGCCCTGGCAGGCGGCGCGCGGTCCAAGGTAGCCCCGAGCGTGGACTTCGACCATAGCTGCTCGGACAGTGTCGAGTACCTGACGCTCAACTTCGGGCCCTTCGAAACAGTGCATCGCTGGCGGCGCCTCCCGCCCTGCGACGAGTTCGTGGGTGCCCGGCGCAGCAAGCACACAGTGGTGGCCTATAAAGATGCCATTTATGTATTTGGTGGAGACAATGGGAAGACCATGCTCAATGACCTCCTGCGGTTCGATGTGAAAGACTGCTCCTGGTGCAGGGCCTTTACCACTGGGACCCCACCGGCCCCCCGTTACCACCACTCGGCCGTCGTCTATGGGAGCAGCATGTTTGTCTTTGGGGGTTACACTGGGGACATTTATTCCAATTCTAACTTGAAGAATAAAAACGACCTCTTTGAATACAAGTTTGCAACTGGCCAGTGGACGGAGTGGAAAATTGAAGGACGGTTGCCAGTCGCTAGGTCAGCCCATGGGGCCACGGTGTACAGTGACAAGCTGTGGATCTTTGCTGGCTATGACGGCAACGCCAGGTTGAATGACATGTGGACAATTGGCCTCCAGGACCGAGAGCTCACCTGCTGGGAGGAGGTGGCCCAGAGTGGCGAGATCCCCCCATCTTGCTGCAACTTCCCCGTGGCTGTGTGCCGGGACAAGATGTTTGTATTCTCTGGGCAAAGCGGAGCCAAAATAACCAACAACCTCTTCCAGTTTGAATTCAAGGACAAGACGTGGACACGCATCCCAACTGAACACCTGCTCCGGGGCTCCCCACCACCCCCGCAGCGGCGCTACGGGCATACCATGGTGGCCTTTGACCGCCACCTCTATGTGTTTGGGGGTGCGGCCGACAACACGCTGCCCAACGAGCTGCACTGCTATGACGTGGACTTCCAGACCTGGGAGGTCGTCCAGCCCAGCTCCGACAGCGAGGTTGGTGGGGCTGAAGTGCCCGAGCGAGCCTGTGCTTCCGAGGAGGTGCCCACCCTGACCTATGAGGAGCGGGTTGGCTTCAAGAAGTCCCGAGATGTGTTTGGCCTGGACTTTGGCACCACCTCAGCCAAGCAGCCCACCCAGCCTGCCTCGGAGCTGCCCAGTGGGAGGCTCTTCCACGCGGCTGCTGTCATCTCGGACGCCATGTACATCTTCGGGGGCACGGTGGACAACAACATCCGCAGCGGGGAGATGTACAGGTTCCAGTTCTCCTGTTACCCTAAATGCACGCTGCACGAGGACTACGGGCGGCTGTGGGAGAGCCGCCAGTTCTGCGACGTGGAGTTCGTGCTGGGTGAGAAGGAGGAGTGCGTGCAGGGCCACGTAGCCATTGTCACAGCGCGGAGCCGCTGGCTTCGCAGGAAGATCACGCAGGCGCGGGAGAGGCTGGCCCAGAAGCTGGAGCAGGAGGCCGCCCCAGTTCCCAGGGAGGCCCCCGGCGTGGCTGCTGGTGGGGCCCGGCCGCCCCTGCTGCACGTGGCCATCCGGGAGGCCGAGGCCCGGCCCTTCGAGGTGCTCATGCAGTTCCTCTACACCGACAAGATCAAATACCCACGGAAAGGCCATGTGGAGGATGTGCTGCTCATCATGGATGTGTACAAACTGGCACTGAGCTTCCAGTTGTGCCGCCTGGAGCAGCTGTGCCGCCAGTACATCGAGGCCTCCGTGGACCTGCAGAACGTGCTGGTTGTGTGCGAGAGTGCCGCCCGGCTGCAGCTGAGCCAACTCAAGGAGCACTGCCTGAACTTCGTGGTAAAGGAGTCCCACTTCAACCAGGTGATCATGATGAAGGAGTTCGAGCGCCTCTCCTCTCCACTGATAGTGGAGATTGTGCGGCGGAAGCAGCAGCCGCCCCCTCGCACTCCCTTGGACCAGCCAGTGGACATTGGCACATCTCTGATCCAGGACATGAAGGCATACCTGGAGGGAGCGGGCGCGGAATTCTGTGACATCACTCTGTTGCTTGACGGGCACCCACGGCCAGCCCACAAGGCTATCCTGGCCGCCCGCTCCAGCTACTTTGAAGCCATGTTCCGGTCCTTCATGCCCGAAGATGGGCAGGTGAACATCTCCATCGGGGAGATGGTGCCCAGCAGGCAGGCCTTCGAGTCCATGCTGCGCTACATCTACTACGGCGAGGTCAACATGCCGCCCGAGGACTCGCTCTACTTGTTTGCGGCCCCCTACTACTACGGCTTCTACAACAACCGGCTGCAGGCGTACTGCAAGCAGAACCTGGAGATGAACGTGACGGTGCAGAACGTGCTGCAGATCCTGGAGGCAGCTGACAAAACGCAGGCACTGGACATGAAGCGGCACTGCCTGCACATCATTGTGCACCAGTTCACCAAGGTCTCCAAGTTGCCCACCCTGCGGTCGCTGAGCCAGCAGCTGCTGCTGGACATCATAGACTCCCTGGCCTCCCACATCTCAGACAAGCAGTGCGCAGAGCTGGGCGCCGACATCTGA
ORF Protein Sequence MAGPGSTGGQIGAAALAGGARSKVAPSVDFDHSCSDSVEYLTLNFGPFETVHRWRRLPPCDEFVGARRSKHTVVAYKDAIYVFGGDNGKTMLNDLLRFDVKDCSWCRAFTTGTPPAPRYHHSAVVYGSSMFVFGGYTGDIYSNSNLKNKNDLFEYKFATGQWTEWKIEGRLPVARSAHGATVYSDKLWIFAGYDGNARLNDMWTIGLQDRELTCWEEVAQSGEIPPSCCNFPVAVCRDKMFVFSGQSGAKITNNLFQFEFKDKTWTRIPTEHLLRGSPPPPQRRYGHTMVAFDRHLYVFGGAADNTLPNELHCYDVDFQTWEVVQPSSDSEVGGAEVPERACASEEVPTLTYEERVGFKKSRDVFGLDFGTTSAKQPTQPASELPSGRLFHAAAVISDAMYIFGGTVDNNIRSGEMYRFQFSCYPKCTLHEDYGRLWESRQFCDVEFVLGEKEECVQGHVAIVTARSRWLRRKITQARERLAQKLEQEAAPVPREAPGVAAGGARPPLLHVAIREAEARPFEVLMQFLYTDKIKYPRKGHVEDVLLIMDVYKLALSFQLCRLEQLCRQYIEASVDLQNVLVVCESAARLQLSQLKEHCLNFVVKESHFNQVIMMKEFERLSSPLIVEIVRRKQQPPPRTPLDQPVDIGTSLIQDMKAYLEGAGAEFCDITLLLDGHPRPAHKAILAARSSYFEAMFRSFMPEDGQVNISIGEMVPSRQAFESMLRYIYYGEVNMPPEDSLYLFAAPYYYGFYNNRLQAYCKQNLEMNVTVQNVLQILEAADKTQALDMKRHCLHIIVHQFTKVSKLPTLRSLSQQLLLDIIDSLASHISDKQCAELGADI

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    ORF Viral Vector pGMLV001650 Human LZTR1 Lentivirus plasmid




    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.